acemetacin
This page covers all acemetacin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Lactoylglutathione lyase.
Targets
Phase 2 pipeline (1)
- Bay F 4975 · Immunology
Acemetacin works by inhibiting the enzyme lactoylglutathione lyase, which is involved in the breakdown of certain inflammatory mediators.
Patent intelligence
- acemetacin patent landscape — aggregated cliff calendar, attackable patents, originator estates